(Q73616930)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Mori T

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Okamoto S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Matsuoka S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Yajima T

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Wakui M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Watanabe R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Ishida A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Iwao Y

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Mukai M

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Hibi T

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Ikeda Y

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

765-769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10745263%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702227

5 November 2019

exact match

0 references

cites work

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021

Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021

Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702227

7 January 2021